Combinatorial Chemistry Online Volume 17, Issue 6, June 2015  by Terrett, N.K.
Combinatorial Chemistry - An Online Journal 17 (2015) 21–24Contents lists available at ScienceDirect
Combinatorial Chemistry - An Online Journal
journal homepage: www.elsevier .com/locate /comcheCombinatorial Chemistry Online Volume 17, Issue 6, June 2015
N.K. Terrett
Ensemble Therapeutics Corp., Cambridge, MA 02139, USA1. Current literature highlights
1.1. Macrocyclic XIAP antagonists from a DNA-programmed chemistry
library
X-Chromosome-linked Inhibitor of Apoptosis Protein (XIAP) is
an endogenous protein that binds and inhibits the activation of
caspases responsible for programmed cell death or apoptosis.
Increased XIAP expression often correlates with poor clinical
outcomes in cancer treatment, as XIAP prevents the natural
apoptosis of tumor cells. Small molecule antagonists of XIAP
have been recognized as agents that have the potential to accel-
erate apoptosis and can result in tumor shrinkage. A recent
paper describes the discovery of novel XIAP antagonists from a
library of macrocycles generated using DNA-programmed chem-
istry [1].
DNA-programmed chemistry is a compound library technology
in which small molecules being synthesized have their preparation
dictated by speciﬁc DNA base sequences. As the small molecule is
built up from individual building blocks, they are selectively intro-
duced by speciﬁc double-stranded DNA duplex formation, bringing
the reacting components into close proximity, ensuring high ﬁde-
lity between the DNA base sequence and ﬁnal product structure.
After completion of the library, afﬁnity selection assays can reveal
active compounds and their associated SAR by reading the
attached DNA base sequences. From a library of 160,000 macro-
cyclic peptidomimetics based on the N-terminal tetrapeptide
sequence AVPI, of the endogenous XIAP inhibitor known as Smac,
a number of compounds were discovered that had weak afﬁnity
for the BIR3 domain of XIAP – the part of the protein that seques-
ters caspase-9. For example, compound 1was found to have an IC50
value for BIR3 of 1.3 lM, but this and other compounds from the
library had no measurable afﬁnity for the BIR2 domain of XIAP
responsible for sequestering caspases-3 and -7. Consequently a fol-
low-up library of 1,800 compounds was designed, synthesized and
screened to exploit the SAR so far discovered, and in the hope that
combined inhibitors of both BIR domains might be discovered. This
subsidiary library was successful in ﬁnding such combination
antagonists including compound 2 (BIR2 IC50 = 4.9 lM; BIR3
IC50 = 0.39 lM).http://dx.doi.org/10.1016/j.comche.2015.04.002
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Subsequent optimization of compounds through medicinal chem-
istry discovered superior XIAP antagonists in which the peptide
sequence was cyclized from the P3 proline group to the P5 position
(e.g. compound 3, BIR2 IC50 = 140 nM; BIR3 IC50 = 160 nM).
Ultimately, by preparing dimeric macrocycles that contained two
binding epitopes, XIAP antagonists were discovered with superior
afﬁnity and the ability to bind to both BIR domains simultaneously
(e.g. compound 4). These macrocycles also had potent functional
activity in a caspase rescue assay. Incubation of the compounds in
a tumor cell lysate in the presence of recombinant XIAP BIR2-3
protein resulted in appreciable increase in pro-apoptotic caspase con-
centrations. Compound 4 also exhibited signiﬁcant anti-proliferative
activity in cancer cell apoptosis models against human breast
cancer (MDA-MB-231) and melanoma (A875) cell-lines. Having
demonstrated that this compound exhibited satisfactory exposure
in mice following intravenous administration, it was progressed
to a human melanoma tumor xenograft mouse model. A 30 mg/kg
dose was administered intraperitoneally every three days resulting
in tumor regression that lasted 12 days following the ﬁfth and ﬁnal
dose.
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In addition to inhibition of the XIAP BIR2 and 3 domains, the key
compounds in this publication also have afﬁnity for the related
cIAP1 protein. There are currently a number of small molecules, that
are potent antagonists of both XIAP and cIAP, in development for
cancer therapy, and this new series of dimeric macrocycle offers
an alternative structural class of potent IAP inhibitor.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
No papers this month.
2.2. Solution-phase synthesis
An efﬁcient and general protocol has been described for the
synthesis of bisindolylmethanes by the reaction of indole with
aldehydes in the presence of BF3OEt2. The method is rapid and
applicable for aromatic, heteroaromatic, and aliphatic aldehydes
[2].
A one-pot, sulfuric acid-promoted, dehydro-aromatization
reaction to rapidly convert pseudopterosins into 14,15-dihydro-
elisabatin B has been reported. A mechanism invoking redox
cycling between the substrate catechol and ortho-quinone moieties
is proposed. This method opens up a unique route to rapidly pro-
vide libraries of novel marine natural product derivatives for drug
discovery [3].
An efﬁcient and environment-friendly method for the synthesis
of benzopyranopyrimidines has been developed using the ultra-
sound-mediated condensation of salicylic aldehydes, malononitrile
and secondary amines under solvent-free conditions. The reaction
proceeds at room temperature in the presence of polystyrene sup-
ported p-toluenesulfonic acid to give the desired products in good
to excellent yield [4].
A concise and efﬁcient three-component synthesis of diverse
ﬂuorine-substituted bicyclic pyridines has been achieved by
reﬂuxing a mixture of different types of heterocyclic ketene
aminals, triethoxymethane, and ﬂuorine-containing methylene
compounds under solvent-free and catalyst-free conditions. As
these bicyclic pyridines provide new opportunities for drugdiscovery, a library of ﬂuorine-substituted bicyclic pyridines has
been rapidly constructed [5].
Chondroitin sulfate (CS), which belongs to the glycosaminogly-
can superfamily, is a linear sulfated polysaccharide involved in var-
ious biological processes. The CS structure is very heterogeneous
and contains various sulfation patterns owing to the multiple
and random enzymatic modiﬁcations that occur during its biosyn-
thesis. In a recent study, a common intermediate possessing an
orthogonally removable protective group was designed and a
library of all 16 types of CS disaccharide structure generated by
sulfation was systematically synthesized [6].
2.3. Scaffolds and synthons for combinatorial libraries
A new bis-cationic cyclic amino acid, 9-amino-3,7-diazabicy-
clo[3.3.1]nonane-9-carboxylic acid (9-amino-bispidine-9-car-
boxylic acid; Abp), which is available for both solution phase and
solid phase peptide synthesis, has been designed and synthesized.
A heterotripeptide Cbz-Leu-Abp-Ala-OMe containing Abp has also
been prepared, and its dominant conformation analyzed by exam-
ining NMR and IR spectra and performing molecular modeling. This
tripeptide formed a b-turn structure as its preferred conformation
in solution [7].
2.4. Solid-phase supported reagents
A ﬂuorous Grubbs–Hoveyda metathesis catalyst supported on
Teﬂon powder, has been prepared. By modulating the
hydrophobicity of the reaction medium at the end of a reaction,
the supported catalyst could be recovered by simple ﬁltration even
though the catalyst existed in a homogeneous state during the
reaction. In RCM reactions, the catalyst could be reused up to three
times with only a slight loss in reactivity with each subsequent
cycle [8].
Copper nanoparticles have been supported and modiﬁed by car-
bon nitride, used as a support and investigated as an immobilized
N-donor ligand. The modiﬁed nanoparticle catalyst was evaluated
with the oxidation of propargylic alcohols and showed catalytic
efﬁciency as well as a signiﬁcant ligand or support effect in the
reaction [9].
A simple and efﬁcient method for the synthesis of pharmaceu-
tically relevant propargylamines through a one-pot three-compo-
nent coupling reaction using nano Au/CeO2 as a heterogeneous
catalyst has been reported. The reactions were carried out using
a mixture of amines, CH2Cl2, and terminal alkynes [10].
Two convenient green protocols for the synthesis of b-amino
ketones have been developed. The approaches involve one-pot
aza-Michael-type and Mannich-type reactions of a series of alde-
hydes, ketones, and amines in the presence of a catalytic amount
of the magnetic solid sulfonic acid catalyst, Fe3O4@SiO2@Me&Et-
PhSO3H, at room temperature. The catalyst can be reused four
times without loss of activity [11].
2.5. Novel resins, linkers and techniques
No papers this month.
2.6. Library applications
A series of structurally diverse 4-bromo spiro-isoxazolines pos-
sessing a variety of aromatic and aliphatic substituents at the 3
position, have been synthesized through a 1,3-dipolar cycloaddi-
tion followed by intramolecular cyclization. Antiproliferative activ-
ity of the compounds was evaluated in vitro by using two breast
cancer cell lines (MCF-7 and MDA-MB-231) and two prostate
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and IC50 values were obtained [12].
A catalyst-free synthesis of 6,9-dihydro-[1,3]dioxolo[4,5-g]
thieno[3,4-b]quinolin-8(5H)-ones as novel analogs of podophyllo-
toxins has been developed by a three-component reaction of
aldehydes, ethyl 2,4-dioxotetrahydrothiophene-3-carboxylate and
3,4-(methylenedioxy)aniline. This methodology not only provided
a new chemical library for the screening of anticancer activity, but
also features excellent isolated yields, short reaction time, simple
work up procedure and little environmental impact [13].
The b-OG pocket is a cavity in the ﬂavivirus envelope (E) protein
that has been identiﬁed as a promising site for the design of antivi-
ral agents that interfere with virus entry into the host cell. A recent
study explored the generation of a novel class of molecules that are
hybrids between two hit compounds reported previously. First, a
library of twenty hybrid molecules were designed and synthesized,
and antiviral evaluation in a virus-cell-based assay for dengue
virus E carried out [14].
A library of potent inhibitors of polyphenol oxidase and their
structure activity relationships have been described. Azachalcone
derivatives were synthesized and tested for their tyrosinase inhibi-
tory activity, and two compounds strongly inhibited and were
more potent than the positive control kojic acid [15].
The sex peptide receptor in Drosophila melanogaster (DrmSPR) is
an interesting G protein-coupled receptor that is involved in post-
mating responses such as increased egg-laying and decreased
receptivity of the female. To discover small molecule agonists for
DrmSPR, a compound library based on a pyrazolodiazepine scaf-
fold, previously reported as a potential privileged structure, was
screened. Structure–activity relationship studies of the hit
compounds, were explored through analog synthesis resulting in
6-benzyl pyrazolodiazepine derivatives found to be small molecule
agonists for DrmSPR [16].
Current FDA-approved chemotherapeutic antimetabolites elicit
severe side effects that warrant their improvement. A recent pub-
lication describes the design of compounds with mechanisms of
action focusing on inhibiting DNA replication rather than targeting
multiple pathways. As 5-(a-substituted-2-nitrobenzyloxy)methy-
luridine-50-triphosphates had previously been revealed as synthe-
sis terminators, a library of 35 thymidine analogs was synthesized
and evaluated in an MTT cell viability assay of MCF-7 breast cancer
cells [17].
Rapid and efﬁcient synthesis of a phenyl-1H-1,2,3-triazole
library has enabled cost-effective biological testing of a range of
novel non-steroidal anti-inﬂammatory drugs with potential for
improved drug efﬁcacy and toxicity proﬁles. Anti-inﬂammatory
activities of the phenyl-1H-1,2,3-triazole analogs synthesized were
assessed using the xylene-induced ear edema mouse model. At
least four analogs showed more potent effects than the reference
anti-inﬂammatory drug diclofenac at the same dose of 25 mg/kg
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